β€οΈ Metformin not a heart health game-changer
The Met-HeFT trial found no significant evidence that metformin protects against cardiovascular issues in heart failure patients. This study, conducted in 23 centers in Denmark, involved 940 participants who were randomized to metformin or placebo. The trial tracked outcomes for 3.7 years, showing no difference in death or worsening heart failure rates. Researchers concluded that while metformin helps lower glucose, it lacks independent cardioprotective benefits. The results were presented at ESC Congress 2026 in Munich, Germany. π©Ί